RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$43.59
-0.16%
Mkt Cap $2.20B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (11 analysts)
$56.40
Range $43.00 – $66.00
Implied Upside
+29.4%
Consensus $56.40 vs current $43.59